Tetra’s Qixleef Product Sees Potential Global Market Expansion
Tetra Bio Pharma (TSXV: TBP) announced further details surrounding its FDA clinical traisl of Qixleef this morning, including the expansion
Read more
Qixleef
the deep dive
Providing stock analysis for investors of the Canadian junior markets